*
Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable
54321NA
The skills learned in this CME course enhanced my professional competence.
The skills learned in this CME course will be applied in the treatment of my patients
*
Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable
54321NA
Describe and be familiar with current T-cell therapy approaches.
Examine and have a better understanding on how T-cells are generated and currently used in the clinic.
Analyze challenged and opportunities in developing T-cell therapies for pediatric cancer.
Summarize the meaning and use of histologic necrosis following initial chemotherapy in the treatment of osteosarcoma.
Describe the evolving role of genomic profiling in the diagnosis and treatment of osteosarcoma.
Implement intraoperative MRI, computed tomography and ultrasound to maximize the extent of tumor resection in a single sitting.
Describe intraoperative neurophysiological monitoring that has been successful to assist in the safe remover of tumors in eloquent areas of the brain.
Describe selected pediatric cancer diagnosis and associated nutrition risks and complications.
Identify caregivers who would benefit from nutrition referral to assist with nutrition care planning responsibilities during selected treatment roadmaps.
Discuss available nutrition guidelines and best practice for the pediatric cancer patient survivor.
Apply tumor precision diagnostics in order to improve patient care.
Assess molecular studies that have led to the identification of distinct tumor subgroups in pediatric brain tumors.
Describe current CD19 CAR T-cell therapy outcomes and limitations.
Assess and familiarize the onset, optimal management and results of anti-tumor efficacy of CAR T-cell toxicities.
Describe the value of dose intensity in the treatment of newly diagnosed EWING sarcoma.
Analyze the controversy around the use of high dose therapy with autologous stem cell support in the treatment of Ewing sarcoma.
Describe robotic surgery in pediatric cancer care.
Analyze potential usage of robotic surgery in pediatric cancer.
Demonstrate pediatric cancer surgery case presentations
Identify selected pediatric cancer diagnosis and associated nutrition risks and complications.
Discuss nutrition risks associated with pediatric cancer.
Discuss common nutrition diagnosis associated with pediatric cancer treatment modalities.
*
Scoring key: 5=Very effective, 4= Effective, 3= Somewhat effective, 2= Slightly effective, 1= Completely Ineffective, N/A= Not Applicable/Did Not Attend
54321NA
​​Immunotherapy in Pediatric Tumors - Stephen Gottschalk, M.D.
Robotics as enhancement to cancer surgery in children - Faud Alkhoury, M.D.
Update on Neurosurgical Advances in Pediatric Tumors - Toba N. Niazi, M.D.
Pediatric Nutrition and Oncology - Dominique Symonette, M.S., RDN
Molecular Classification of Brain Tumors - Michael D. Taylor, M.D., Ph.D.
CAR T Cells for Solid Tumors: What are the Challenges? - Stephen Gottschalk, M.D.
Ewing Sarcoma Update - Paul A. Meyers, M.D.
Managing Treatment Side Effects and Maintaining Proper Nutrition - Dominique Symonette, M.S.,
Osteosarcoma Update - Paul A. Meyers, M.D.
*
*
*
*
*
*
*
*
*
*